Our catalog related to treatment and diagnosis includes:
TREATMENT AND DIAGNOSIS
• INDUSTRIAL PROPERTY (Patents, utility models, and associated know-how):
| Code | Title | Type | Description | PDF – Technology offering |
|---|---|---|---|---|
| FCAD-21005 | Clinical panel with biomarkers for detecting statin intolerance in patients at high cardiovascular risk | Diagnosis (cardiology) | Use of miRNA panels as biomarkers for the detection of statin intolerance. |
Spanish English |
| FCAD-21002 | Organic compounds for the treatment of diabetic retinopathy and nephropathy | Therapy | Molecule with anti-inflammatory and chemopreventive potential in inflammatory processes in general, in diseases caused by underlying inflammatory processes, and in inflammatory processes related to the development of diabetes mellitus and its complications. |
Spanish English |
| UCA-P201800246 | Composition of promoting the formation of neurons in culture and in brain injuries | Therapy | This invention relates to the use of the compound EOF2 or a pharmacologically active salt thereof to promote the differentiation of neural precursors or neural stem cells into neurons in culture and in brain injuries. Additionally, it also relates to its use for the treatment of CNS injuries involving neuronal loss. | ND |
| UCA-P201600138 | Use of mango leaf extract for the treatment of neurodegenerative diseases | Therapy | The present invention relates to the use of an extract for the preparation of a Composition or nutraceutical Composition useful in the treatment of CNS diseases involving inflammation. These are the most common forms of dementia and account for approximately 80% of cases. | Spanish (UCA website) |
| UCA-P201830615 | Methods for the diagnosis and/or treatment of neurodegenerative diseases | Diagnosis, Therapy | In vitro method for detecting at least one neurodegenerative disease, for monitoring the efficacy of a treatment and/or for predicting the response to a treatment, and for identifying candidate compounds useful for treatment. Furthermore, the present invention relates to therapeutic targets for use in the treatment of neurodegenerative diseases and also to compounds capable of inhibiting said therapeutic targets with the aim of improving the health of patients suffering from a neurodegenerative disease. | ND |
| FCAD-21002 | Computer-implemented method for converting a high-resolution digital image into a DICOM pyramid image | ICT Diagnosis | New computer-implemented method designed specifically to convert a high-resolution image, for example, an image obtained after scanning or digitizing a histological or cytological preparation in Pathological Anatomy, from a source format to a DICOM format. | ND |
| FCAD-23001 | Pharmacological inhibitors of NLRP1 and NLPR3 inflammasomes | Therapy | Specific inhibitors that simultaneously block the NLRP1 and NLRP3 inflammatory complexes, reducing IL-1β- and IL-18-mediated inflammation with low cellular toxicity, for the treatment of inflammatory diseases. |
Spanish English |
| FCAD-23010 | Stabilized mixture based on natural sweeteners for the manufacture of ice cream suitable for consumption by people with diabetes, manufacturing process, and uses | Research model | Stabilized blend of natural sweeteners, based on tagatose, designed for making ice cream suitable for people with diabetes, maintaining texture, flavor, and quality without affecting blood sugar levels. |
Spanish English |
| FCAD-24001 | Panel of protein markers for predicting cardiovascular events resulting from the atherosclerotic process | Personalized medicine | Panel of protein biomarkers to predict the progression of atherosclerosis in patients with dyslipidemia, enabling more accurate risk stratification and personalized management of cardiovascular disease. |
Spanish English |
| FCAD-24002 | Development of modular and/or reversible chimeric antigen receptors (CARs) mediated by inteins | Therapy | Use of split inteins to improve industrial processes, such as the modular creation of CAR receptors that recognize multiple antigens, the evaluation of protein domains without expressing complete molecules, and the dynamic modulation of CAR activity through controlled elimination of active domains. |
Spanish English |
CODE: FCAD-21005
Title: Clinical panel with biomarkers for detecting statin intolerance in patients at high cardiovascular risk
TYPE: Diagnostic (cardiology)
DESCRIPTION: Use of miRNA panels as biomarkers for detecting statin intolerance.
CODE: FCAD-21002
Title: Organic compounds for the treatment of diabetic retinopathy and nephropathy
TYPE: Therapy
DESCRIPTION: Molecule with anti-inflammatory and chemopreventive potential in inflammatory processes in general, in diseases caused by underlying inflammatory processes, and in inflammatory processes related to the development of diabetes mellitus and its complications.
CODE: UCA-P201800246
Title: Composition of promoting neuron formation in culture and in brain injuries
TYPE: Therapy
DESCRIPTION: This invention relates to the use of the compound EOF2 or a pharmacologically active salt of said compound to promote the differentiation of neural precursors or neural stem cells into neurons in culture and in brain injuries. Additionally, it also relates to its use for the treatment of CNS injuries that result in neuronal loss.
PDF - TECHNOLOGY OFFER: ND
CODE: UCA-P201600138
Title: Use of mango leaf extract for the treatment of neurodegenerative diseases
TYPE: Therapy
DESCRIPTION: The present invention relates to the use of an extract for the preparation of a Composition or nutraceutical Composition useful in the treatment of CNS diseases that involve inflammation. These are the most common forms of dementia and account for approximately 80% of cases.
PDF - TECHNOLOGY OFFER: Spanish (UCA website)
CODE: UCA-P201830615
Title: Methods for the diagnosis and/or treatment of neurodegenerative diseases
TYPE: Diagnosis, Therapy
DESCRIPTION: An in vitro method for detecting at least one neurodegenerative disease, for monitoring the efficacy of a treatment and/or for predicting the response to a treatment, and for identifying useful candidate compounds for treatment. Furthermore, the present invention relates to therapeutic targets for use in the treatment of neurodegenerative diseases and also to compounds capable of inhibiting said therapeutic targets with the aim of improving the health of patients suffering from a neurodegenerative disease.
PDF - TECHNOLOGY OFFER: ND
CODE: FCAD-17001
Title: Computer-implemented method for converting a high-resolution digital image into a DICOM pyramid image
TYPE: ICT Diagnosis
DESCRIPTION: New computer-implemented method designed specifically to convert a high-resolution image, for example, an image obtained after scanning or digitizing a histological or cytological specimen in Pathological Anatomy, from a source format to a DICOM format.
PDF - TECHNOLOGY OFFER: ND
CODE: FCAD-23001
Title: Pharmacological inhibitors of NLRP1 and NLPR3 inflammasomes
TYPE: Therapy
DESCRIPTION: Specific inhibitors that simultaneously block the NLRP1 and NLRP3 inflammatory complexes, reducing IL-1β- and IL-18-mediated inflammation with low cellular toxicity, for the treatment of inflammatory diseases.
CODE: FCAD-23010
Title: Stabilized mixture based on natural sweeteners for the manufacture of ice cream suitable for consumption by people with diabetes, manufacturing process, and uses
TYPE: Research model
DESCRIPTION: Stabilized blend of natural sweeteners, based on tagatose, designed for making ice cream suitable for people with diabetes, maintaining texture, flavor, and quality without affecting blood sugar levels.
CODE: FCAD-24001
Title: Panel of protein markers for predicting cardiovascular events resulting from the atherosclerotic process
TYPE: Personalized medicine
DESCRIPTION: Panel of protein biomarkers to predict the progression of atherosclerosis in patients with dyslipidemia, enabling more accurate risk stratification and personalized management of cardiovascular disease.
CODE: FCAD-24002
Title: Development of modular and/or reversible chimeric antigen receptors (CARs) mediated by inteins
TYPE: Therapy
DESCRIPTION: Use of split inteins to improve industrial processes, such as the modular creation of CAR receptors that recognize multiple antigens, the evaluation of protein domains without expressing complete molecules, and the dynamic modulation of CAR activity through controlled elimination of active domains.
• INTELLECTUAL PROPERTY (know-how, software, App):
| Code | Title | Type | Description | PDF – Technology offering |
|---|---|---|---|---|
| FCAD-22002 | MELAGE | Diagnostic software | Software that facilitates the visualization and management of ultrasound scans and brain MRIs of newborns to improve the early diagnosis of motor/cognitive impairments. |
Spanish English |
CODE: FCAD-22002
Title: MELAGE
TYPE: Diagnostic software
DESCRIPTION: Software that facilitates the visualization and management of ultrasound scans and brain MRIs of newborns to improve the early diagnosis of motor/cognitive impairments.
If you have any problems downloading the above file, you can access it via the following link link.